CVE-2018-10595
A vulnerability in ReadA version 1.1.0.2 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor) to issue SQL commands, which may result in loss or…
Does this matter?
Lower severity and a low EPSS score (0.41%). Track it; it rarely justifies an emergency change on its own.
Description
A vulnerability in ReadA version 1.1.0.2 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor) to issue SQL commands, which may result in loss or corruption of data.
- CVSS 3.0
- 6.3 MEDIUMCVSS:3.0/AV:A/AC:H/PR:H/UI:R/S:U/C:H/I:H/A:H
- EPSS
- 0.41% probability · 36th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-356, CWE-89
- Affected
- bd/database manager · bd/performa · bd/reada
- Source
- ics-cert@hq.dhs.gov
EPSS 0.4% since 27 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-142-01Third Party Advisory, US Government Resource
- https://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-bd-kiestra-tla-bd-kiestra-wca-bd-inoqulaVendor Advisory
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-142-01Third Party Advisory, US Government Resource
- https://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-bd-kiestra-tla-bd-kiestra-wca-bd-inoqulaVendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.